137 related articles for article (PubMed ID: 37340663)
1. Development of angiogenic periglomerular microvessels after acute glomerular lesions in IgA nephropathy.
Kamano C; Mii A; Osono E; Kunugi S; Igarashi T; Yanagihara T; Kaneko T; Terasaki M; Shimizu A
Histopathology; 2023 Oct; 83(4):617-630. PubMed ID: 37340663
[TBL] [Abstract][Full Text] [Related]
2. Relevance of periglomerular myofibroblasts in progression of human glomerulonephritis.
Oba S; Kimura K; Suzuki N; Mise N; Tojo A; Miyashita K; Konno Y; Hirata Y; Goto A; Omata M
Am J Kidney Dis; 1998 Sep; 32(3):419-25. PubMed ID: 9740158
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy.
Kusano T; Takano H; Kang D; Nagahama K; Aoki M; Morita M; Kaneko T; Tsuruoka S; Shimizu A
Hum Pathol; 2016 Mar; 49():135-44. PubMed ID: 26826420
[TBL] [Abstract][Full Text] [Related]
4. Acquired glomerular lesions in patients with Down syndrome.
Said SM; Cornell LD; Sethi S; Fidler ME; Al Masri O; Marple J; Nasr SH
Hum Pathol; 2012 Jan; 43(1):81-8. PubMed ID: 21733549
[TBL] [Abstract][Full Text] [Related]
5. From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies.
Kriz W; Hosser H; Hähnel B; Gretz N; Provoost AP
Nephrol Dial Transplant; 1998 Nov; 13(11):2781-98. PubMed ID: 9829480
[TBL] [Abstract][Full Text] [Related]
6. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Troyanov S; Vorobyeva O; Coppo R; Roberts ISD;
Kidney Int; 2024 Jun; 105(6):1279-1290. PubMed ID: 38554992
[TBL] [Abstract][Full Text] [Related]
7. Segmental glomerulosclerosis in IgA nephropathy after renal transplantation: relationship with proteinuria and therapeutic response to enalapril.
Jeong HJ; Kim YS; Kwon KW; Kim MS; Kim S; Choi KH; Lee HY; Han DS; Park K
Clin Transplant; 2003 Apr; 17(2):108-13. PubMed ID: 12709075
[TBL] [Abstract][Full Text] [Related]
8. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
[TBL] [Abstract][Full Text] [Related]
9. A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study.
Kamano C; Shimizu A; Joh K; Hashiguchi A; Hisano S; Katafuchi R; Kawamura T;
Clin Exp Nephrol; 2021 May; 25(5):509-521. PubMed ID: 33595730
[TBL] [Abstract][Full Text] [Related]
10. Macrophages in childhood IgA nephropathy.
Nagata M; Akioka Y; Tsunoda Y; Komatsu Y; Kawaguchi H; Yamaguchi Y; Ito K
Kidney Int; 1995 Aug; 48(2):527-35. PubMed ID: 7564122
[TBL] [Abstract][Full Text] [Related]
11. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
[TBL] [Abstract][Full Text] [Related]
12. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?
Cook HT
Kidney Int; 2011 Mar; 79(6):581-583. PubMed ID: 21358653
[TBL] [Abstract][Full Text] [Related]
13. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
[TBL] [Abstract][Full Text] [Related]
14. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
Weber CL; Rose CL; Magil AB
Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
[TBL] [Abstract][Full Text] [Related]
15. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
[TBL] [Abstract][Full Text] [Related]
16. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.
Trimarchi H; Coppo R
Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265
[TBL] [Abstract][Full Text] [Related]
17. [Severe proteinuria in IgA nephropathy. Clinicopathological study of 8 cases with 100 serial sections].
Shouno Y; Shimokama T; Sakemi T; Harada A; Watanabe T
Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1043-50. PubMed ID: 8230814
[TBL] [Abstract][Full Text] [Related]
18. Glomerulo-tubular junction stenosis as a factor contributing to glomerular obsolescence in IgA nephropathy.
Sato M; Hotta O; Taguma Y
J Pathol; 2002 May; 197(1):14-9. PubMed ID: 12081198
[TBL] [Abstract][Full Text] [Related]
19. Focal segmental glomerular sclerosis: the cellular lesion.
Schwartz MM; Lewis EJ
Kidney Int; 1985 Dec; 28(6):968-74. PubMed ID: 4087702
[TBL] [Abstract][Full Text] [Related]
20. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
